Back in October, GN Hearing had to downgrade its 2021 financial guidance considerably as two key product launches were delayed. Progress is now being made, and Chairman of GN Store Nord Per Wold-Olsen expects the products in question to hit the market in H1 2022, reports the Danish business daily Børsen.
”It is safe to presume that they will be launched during the first half year,” Wold-Olsen tells Børsen, underscoring that the causes behind the delays have been dealt with.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Fruergaard leveraging experience from Danish partnerships in key roles in Brussels
Experiences from Danish climate partnerships are among the tools that can be leveraged when Novo Nordisk CEO Lars Fruergaard begins stepping up efforts in the life science sector’s central organs in Brussels. ”I’ve been fired up by the intimacy and shared vision we could see in Denmark,” he tells MedWatch.
Stallergenes slapped with injunction
There are still issues with Stallergenes Greer’s factory in Antony, the Agence Nationale de Sécurité du Médicament has concluded.
Overview: Pharma giants and Bavarian Nordic fight over billion-dollar vaccine market
There is currently no approved vaccine for RSV, which causes serious illness and can be deadly for newborns and the elderly. The race to come first to the vaccine market is heating up, while more companies are close to completing phase III studies. Get an overview of their progress here.
Eargo raises USD 100m from investment firm
US-based Eargo, which is run by a Dane, has entered an agreement with an investment firm which is injecting USD 100m into the company.
US authorities expand monkeypox vaccine plan
More Americans will be offered a monkeypox vaccine.
Training Supporter with high drive 
Corporate Quality Compliance Specialist for Audit Management 
Key Account Manager Vision Care, Nordic 
Director Regulatory Affairs 
Device Associate Director/Senior Project Leader 
Global Product Manager - ENT 
Senior Manager/Associate Director, Global Regulatory Affairs, CMC 
Senior Scientist for Analytical Development 
Principal Scientist – Pharmacology 
Quality Management System Compliance Department Manager 
QA Senior Specialist 
Senior Project Manager (GMP - Life Science) 
Regulatory Affairs Manager - Maternity Cover 
Nordic Medical Advisor